At the forefront of ophthalmic innovation, the Department of Ophthalmology at the Icahn School of Medicine at Mount Sinai provides training experiences, translational, clinical, and bench research, and internationally acclaimed clinical care in all ophthalmic subspecialties. Our physicians and scientists are renowned leaders in their fields, conducting research on many blinding conditions, including the cornea, uveitis, anterior segment physiology, and glaucoma.

Our strengths span the translational spectrum—from unraveling disease mechanisms to developing novel diagnostics, therapies, and interventions that restore and preserve vision.

With funding from the National Institutes of Health, industry partnerships, and philanthropy, our researchers are translating discoveries into breakthrough treatments for patients here and worldwide. We provide unmatched training opportunities and mentorship, equipping the next generation of clinician-scientists to advance ophthalmology.

By combining our expansive expertise and resources, we will continue driving innovations to deliver the best possible outcomes for patients facing eye diseases and vision loss. The future of ophthalmology is bright.

James C. Tsai, MD, MBA
President, New York Eye and Ear Infirmary of Mount Sinai
Delafield-Rodgers Professor and Chair, Department of Ophthalmology,
Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System